ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Dana-Farber, Harvard And Affiliates Form Cancer Center.

February 4, 2000

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978